- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 392
Shenzhen Capital cases corporates for $290m healthcare fund
Industrial Bank and Ping An Insurance Real Estate Investment are among the limited partners for a healthcare-focused fund launched by Shenzhen Capital that is targeting a $116m first close.
Jul 26, 2019TScan takes in $48m
The Alphabet and Novartis-backed T cell cancer therapy developer has secured series B capital that took its overall funding to $48m.
Jul 26, 2019Mingdu mingles for $14.5m
Cash Capital joined a unit of Red Star Macalline to back Mingdu Intelligent, which provides drug manufacturing services mainly related to data management and quality control.
Jul 26, 2019Qihan Biotech receives $20m funding transplant
Legend Holdings vehicle Legend Star took part in a round that will fund the further development of Qihan Biotech's organ transplant technology.
Jul 26, 2019Daily deal net July 25, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jul 25, 2019X-Vax packs $56m into series A
Johnson & Johnson, Alexandria Venture Investments and Serum Institute of India contributed to a series A for Albert Einstein College of Medicine spinout X-Vax.
Jul 25, 2019Ireland launches 30 spinouts in 2018
A survey by Knowledge Transfer Ireland suggests there are now 119 active spinouts in Ireland, with Irish universities responsible for 76% of the country's patent filings last year.
Jul 25, 2019Pennsylvania Biotech eyes $50m fund
Pennsylvania Biotechnology Center of Bucks County is launching a $50m fund to invest in resident startups and to help establish university spinouts.
Jul 25, 2019Freenome passes series B test with $160m
Roche Ventures, Kaiser Permanente Ventures, and Alphabet subsidiaries Verily and GV took part in a round that boosted the cancer testing platform developer's total funding to more than $237m.
Jul 25, 2019X-Vax packs $56m into series A round
Johnson & Johnson, Alexandria Venture Investments and Serum Institute of India contributed to the first round to be disclosed by herpes vaccine developer X-Vax Technology.
Jul 25, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


